Management of Portal Hypertension in patients with HCC is very challenging. There are several areas that remain controversial including bleeding risk from gastroesophageal varices in the setting of systemic therapy with Anti-VEGF based combinations for HCC. The optimal management strategy in such patients requires a multidisciplinary approach. Additionally, among patients with HCC presenting with variceal bleeding, the role of TPC to manage variceal bleeding event and prevent future bleeding during the HCC treatment is unclear. Careful selection of potential candidates is key in these complicated situations. This webinar is intended to provide a framework and answer commonly encountered questions in the scenarios based on available evidence. This webinar is intended for gastroenterologists, hepatologists, fellows, trainees and nurse practitioners. Others with an interest in management of portal hypertension are invited to attend.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 1001 North Fairfax
Top 6 courses
-

-

-

-

-

-
PSVD-NCPF Nomenclature0.5 Credits
Specialties served/covered
- Adolescent Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Interventional Radiology
- Medical Oncology
- Patient Safety & Quality Improvement
- Pediatric Gastroenterology
- Pediatric Transplant Hepatology
- Radiation Oncology
- Surgical Oncology
- Transplant Hepatology
- Cross-Specialty
- GI & Liver
- Internal Medicine
- Medical Subspecialties
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Radiology
- No reviews yet. Be the first to share yours.


